530313.BO Stock Analysis
53
Uncovered
Kimia Biosciences Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Kimia Biosciences Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in New Delhi, Delhi and currently employs 241 full-time employees. The company went IPO on 2016-03-21. The firm provides its products under various categories: active pharmaceutical ingredients (APIs), intermediates and formulations. The firm's commercial products include acotiamide hydrochloride hydrate, azelnidipine, benfotiamine, benidipine hydrochloride, citicoline sodium, gliclazide, levosulpiride, luliconazole, oxaceprol, prucalopride succinate, teneligliptin hydrobromide hydrate, vildagliptin, fimasartantrihydrate potassium, obeticholic acid and ursodeoxycholic acid.